1
|
Rex N, Oueidat K, Ospel J, McDonough R, Rinkel L, Baird GL, Collins S, Jindal G, Alvin MD, Boxerman J, Barber P, Jayaraman M, Smith W, Amirault-Capuano A, Hill M, Goyal M, McTaggart R. Modeling diffusion-weighted imaging lesion expansion between 2 and 24 h after endovascular thrombectomy in acute ischemic stroke. Neuroradiology 2024; 66:621-629. [PMID: 38277008 DOI: 10.1007/s00234-024-03294-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Accepted: 01/10/2024] [Indexed: 01/27/2024]
Abstract
PURPOSE Diffusion-weighted imaging (DWI) lesion expansion after endovascular thrombectomy (EVT) is not well characterized. We used serial diffusion-weighted magnetic resonance imaging (MRI) to measure lesion expansion between 2 and 24 h after EVT. METHODS In this single-center observational analysis of patients with acute ischemic stroke due to large vessel occlusion, DWI was performed post-EVT (< 2 h after closure) and 24-h later. DWI lesion expansion was evaluated using multivariate generalized linear mixed modeling with various clinical moderators. RESULTS We included 151 patients, of which 133 (88%) had DWI lesion expansion, defined as a positive change in lesion volume between 2 and 24 h. In an unadjusted analysis, median baseline DWI lesion volume immediately post-EVT was 15.0 mL (IQR: 6.6-36.8) and median DWI lesion volume 24 h post-EVT was 20.8 mL (IQR: 9.4-66.6), representing a median change of 6.1 mL (IQR: 1.5-17.7), or a 39% increase. There were no significant associations among univariable models of lesion expansion. Adjusted models of DWI lesion expansion demonstrated that relative lesion expansion (defined as final/initial DWI lesion volume) was consistent across eTICI scores (0-2a, 0.52%; 2b, 0.49%; 2c-3, 0.42%, p = 0.69). For every 1 mL increase in lesion volume, there was 2% odds of an increase in 90-day mRS (OR: 1.021, 95%CI [1.009, 1.034], p < 0.001). CONCLUSION We observed substantial lesion expansion post-EVT whereby relative lesion expansion was consistent across eTICI categories, and greater absolute lesion expansion was associated with worse clinical outcome. Our findings suggest that alternate endpoints for cerebroprotectant trials may be feasible.
Collapse
Affiliation(s)
- Nathaniel Rex
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
- Department of Radiology, University of Calgary, Calgary, Canada
| | - Karim Oueidat
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Johanna Ospel
- Department of Radiology, University of Calgary, Calgary, Canada
| | | | - Leon Rinkel
- Department of Radiology, University of Calgary, Calgary, Canada
| | - Grayson L Baird
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Scott Collins
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Gaurav Jindal
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Matthew D Alvin
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Jerrold Boxerman
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Phil Barber
- Department of Radiology, University of Calgary, Calgary, Canada
| | - Mahesh Jayaraman
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Wendy Smith
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Amanda Amirault-Capuano
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA
| | - Michael Hill
- Department of Clinical Neuroscience, University of Calgary, Calgary, Canada
| | - Mayank Goyal
- Department of Radiology, University of Calgary, Calgary, Canada
| | - Ryan McTaggart
- Department of Diagnostic Imaging, Brown University, 593 Eddy Street Providence, Providence, RI, 02903, USA.
| |
Collapse
|
2
|
Iheanacho F, Rex N, Oueidat K, Collins S, Baird GL, Kim D, Dubel GJ, Jay BS, Maxwell AWP. Prospective Margin Estimates Predict Local Tumor Progression Following Microwave Ablation of Small Renal Masses. Cardiovasc Intervent Radiol 2024; 47:200-207. [PMID: 38151603 DOI: 10.1007/s00270-023-03635-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Accepted: 11/26/2023] [Indexed: 12/29/2023]
Abstract
PURPOSE To evaluate the relationship between prospectively generated ablative margin estimates and local tumor progression (LTP) among patients undergoing microwave ablation (MWA) of small renal masses (SRMs). MATERIALS AND METHODS Between 2017 and 2020, patients who underwent MWA for SRM were retrospectively identified. During each procedure, segmented kidney and tumor shapes were coregistered with intraprocedural helical CT images obtained after microwave antenna placement. Predicted ablation zone shape and size were then overlaid onto the resultant model, and a model-to-model distance algorithm was employed to calculate multiple ablative margin estimates. LTP was modeled as a function of each margin estimate by hazard regression. Models were evaluated using hazard ratios and Akaike information criterion. Receiver operating characteristic curve area under the curve was also estimated using Harrell's and Uno's C indices (HI and UI, respectively). RESULTS One hundred and twenty-eight patients were evaluated (median age 72.1 years). Mean tumor diameter was 2.4 ± 0.9 cm. LTP was observed in nine (7%) patients. Analysis showed that decreased estimated margin size as measured by first quartile (Q1; 25th percentile), maximum, and average ablative margin metrics was significantly associated with risk of LTP. For every one millimeter increase in Q1, maximum, and mean ablative margin, the hazard of LTP increased 67% (HR: 1.67; 95% CI = 1.25-2.20, UI = 0.93, HI = 0.77), 32% (HR: 1.32; 95% CI 1.09-1.60; UI = 0.93; HI = 0.76), and 48% (HR: 1.48; 95% CI 1.18-1.85; UI = 0.83; HI = 0.75), respectively. CONCLUSION Prospectively generated ablative margin estimates can be used to predict the risk of local tumor progression following microwave ablation of small renal masses. LEVEL OF EVIDENCE 3: Retrospective cohort study.
Collapse
Affiliation(s)
- Franklin Iheanacho
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - Nathaniel Rex
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - Karim Oueidat
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA.
| | - Scott Collins
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - Grayson L Baird
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - DaeHee Kim
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - Gregory J Dubel
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - Bryan S Jay
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| | - Aaron W P Maxwell
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| |
Collapse
|
3
|
Fintelmann FJ, Graur A, Oueidat K, Simon J, Barnes JMH, McDermott S, Genshaft SJ, Healey TT, Suh RD, Maxwell AWP, Abtin F. Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study. AJR Am J Roentgenol 2024; 222:e2330300. [PMID: 37966037 DOI: 10.2214/ajr.23.30300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2023]
Abstract
BACKGROUND. Treatment options for patients with interstitial lung disease (ILD) who develop stage I-II non-small cell lung cancer (NSCLC) are severely limited, given that surgical resection, radiation, and systemic therapy are associated with significant morbidity and mortality. OBJECTIVE. The aim of this study was to evaluate the safety and efficacy of percutaneous ablation of stage I-II NSCLC in patients with ILD. METHODS. This retrospective study included patients with ILD and stage I-II NSCLC treated with percutaneous ablation in three health systems between October 2004 and February 2023. At each site, a single thoracic radiologist, blinded to clinical outcomes, reviewed preprocedural chest CT examinations for the presence and type of ILD according to 2018 criteria proposed by the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. The primary outcome was 90-day major (grade ≥ 3) adverse events, based on Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Secondary outcomes were hospital length of stay (HLOS), local tumor control, and overall survival (OS). RESULTS. The study included 33 patients (19 men, 14 women; median age, 78 years; 16 patients with Eastern Cooperative Oncology Group performance status ≤ 1) with ILD who underwent 42 percutaneous ablation sessions (21 cryoablations, 11 radiofrequency ablations, 10 microwave ablations) of 43 NSCLC tumors ((median tumor size, 1.6 cm; IQR, 1.4-2.5 cm; range, 0.7-5.4 cm; 37 stage I, six stage II). The extent of lung fibrosis was 20% or less in 24 patients; 17 patients had imaging findings of definite or probable usual interstitial pneumonia. The 90-day major adverse event rate was 14% (6/42), including one CTCAE grade 4 event. No acute ILD exacerbation or death occurred within 90 days after ablation. The median HLOS was 1 day (IQR, 0-2 days). Median imaging follow-up for local tumor control was 17 months (IQR, 11-32 months). Median imaging or clinical follow-up for OS was 16 months (IQR, 6-26 months). Local tumor control and OS were 78% and 77%, respectively, at 1 year and 73% and 46% at 2 years. CONCLUSION. Percutaneous ablation appears to be a safe and effective treatment option for stage I-II NSCLC in the setting of ILD after multidisciplinary selection. CLINICAL IMPACT. Patients with ILD and stage I-II NSCLC should be considered for percutaneous ablation given that they are frequently ineligible for surgical resection, radiation, and systemic therapy.
Collapse
Affiliation(s)
- Florian J Fintelmann
- Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114
| | - Alexander Graur
- Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114
- Department of Radiology, Ludwig-Maximilians-University, Munich, Germany
| | - Karim Oueidat
- Department of Diagnostic Imaging, Lifespan Health System, Providence, RI
- Department of Diagnostic Imaging, Warren Alpert Medical School, Brown University, Providence, RI
| | - Judit Simon
- Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114
| | - Jeanna M Harvey Barnes
- Department of Diagnostic Imaging, Lifespan Health System, Providence, RI
- Department of Diagnostic Imaging, Warren Alpert Medical School, Brown University, Providence, RI
| | - Shaunagh McDermott
- Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114
| | - Scott J Genshaft
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA
| | - Terrance T Healey
- Department of Diagnostic Imaging, Lifespan Health System, Providence, RI
- Department of Diagnostic Imaging, Warren Alpert Medical School, Brown University, Providence, RI
| | - Robert D Suh
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA
| | - Aaron W P Maxwell
- Department of Diagnostic Imaging, Lifespan Health System, Providence, RI
- Department of Diagnostic Imaging, Warren Alpert Medical School, Brown University, Providence, RI
| | - Fereidoun Abtin
- Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA
| |
Collapse
|
4
|
Jayaraman MV, Baird G, Oueidat K, Paolucci G, Haas RA, Torabi R, Moldovan K, Rhodes J, Potvin J, Alexander-Scott N, Yaghi S, Madsen T, Furie K, McTaggart RA. Long-term effect of field triage on times to endovascular treatment for emergent large vessel occlusion. J Neurointerv Surg 2023; 15:e86-e92. [PMID: 35896319 DOI: 10.1136/jnis-2022-019250] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Accepted: 07/10/2022] [Indexed: 11/04/2022]
Abstract
BACKGROUND Delays to endovascular therapy (EVT) for stroke may be mitigated with direct field triage to EVT centers. We sought to compare times to treatment over a 5.5 year span between two adjacent states, one with field triage and one without, served by a single comprehensive stroke center (CSC). METHODS During the study period, one of the two states implemented severity-based triage for suspected emergent large vessel occlusion, while in the other state, patients were transported to the closest hospital regardless of severity. We compared times to treatment and clinical outcomes between these two states. We also performed a matched pairs analysis, matching on date treated and distance from field to CSC. RESULTS 639 patients met the inclusion criteria, 407 in State 1 (with field triage) and 232 in State 2 (without field triage). In State 1, scene to EVT decreased 6% (or 8.13 min, p=0.0004) every year but no decrease was observed for State 2 (<1%, p=0.94). Cumulatively over 5.5 years, there was a reduction of 43 min in time to EVT in State 1, but no change in State 2. Lower rates of disability were seen in State 1, both for the entire cohort (all OR 1.22, 95% CI 1.07 to 1.40, p=0.0032) and for those independent at baseline (1.36, 95% CI 1.15 to 1.59, p=0.0003). CONCLUSIONS Comparing adjacent states over time, the implementation of severity-based field triage significantly reduced time to EVT.
Collapse
Affiliation(s)
- Mahesh V Jayaraman
- Diagnostic Imaging, Neurology and Neurosurgery, Brown University, Providence, Rhode Island, USA
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
| | - Grayson Baird
- Diagnostic Imaging, Brown University, Providence, Rhode Island, USA
| | - Karim Oueidat
- Diagnostic Imaging, Brown University, Providence, Rhode Island, USA
| | - Gino Paolucci
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
| | - Richard A Haas
- Diagnostic Imaging, Neurology and Neurosurgery, Brown University, Providence, Rhode Island, USA
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
| | - Radmehr Torabi
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
- Neurosurgery and Diagnostic Imaging, Brown University, Providence, Rhode Island, USA
| | - Krisztina Moldovan
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
- Neurosurgery, Brown University, Providence, Rhode Island, USA
| | - Jason Rhodes
- Department of Health, State of Rhode Island, Providence, Rhode Island, USA
| | - John Potvin
- Division of Emergency Medical Services, City of East Providence, East Providence, Rhode Island, USA
| | | | - Shadi Yaghi
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
- Neurology, Brown University, Providence, Rhode Island, USA
| | - Tracy Madsen
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
- Emergency Medicine, Brown University, Providence, Rhode Island, USA
| | - Karen Furie
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
- Neurology, Brown University, Providence, Rhode Island, USA
| | - Ryan A McTaggart
- Diagnostic Imaging, Neurology and Neurosurgery, Brown University, Providence, Rhode Island, USA
- Neurovascular Center, Rhode Island Hospital, Providence, Rhode Island, USA
| |
Collapse
|
5
|
Atalay MK, Baird GL, Stib MT, George P, Oueidat K, Cronan JJ. The Impact of Emerging Technologies on Residency Selection by Medical Students in 2017 and 2021, With a Focus on Diagnostic Radiology. Acad Radiol 2023; 30:1181-1188. [PMID: 36058817 DOI: 10.1016/j.acra.2022.07.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2022] [Revised: 06/29/2022] [Accepted: 07/07/2022] [Indexed: 11/29/2022]
Abstract
RATIONALE AND OBJECTIVES We sought to determine the perceived impact of artificial intelligence (AI) and other emerging technologies (ET) on various specialties by medical students in both 2017 and 2021 and how this might affect their residency selections. MATERIALS AND METHODS We conducted a brief, anonymous survey of all medical students at a single institution in 2017 and 2021. Survey questions evaluated (1) incentives motivating residency selection and career path, (2) degree of interest in each specialty, (3) perceived effect that ET will have on job prospects for each specialty, and (4) those specialties that students would not consider because of concerns regarding ET. RESULTS A total of 72% (384/532) and 54% (321/598) of medical students participated in the survey in 2017 and 2021, respectively, and results were largely stable. Students perceived ET would reduce job prospects for pathology, diagnostic radiology, and anesthesiology, and enhance prospects for all other specialties (p < 0.01) except dermatology. For both surveys, 23% of students would NOT consider diagnostic radiology because ET would make it obsolete, higher than all other specialties (p < 0.01). Regarding the one student class that was surveyed twice, 50% felt ET would reduce job prospects for radiology in 2017, increasing to 71% in 2021 (p < 0.01), and similar percentages-20% in 2017 and 23% in 2021-said they explicitly would not consider radiology because of concerns levied by ET. CONCLUSIONS Current perceptions of ET likely affect residency selection for a large proportion of medical students and may impact the future of various specialties, particularly diagnostic radiology.
Collapse
Affiliation(s)
- Michael K Atalay
- Department of Diagnostic Imaging (M.K.A., G.L.B., M.T.S., K.O., J.J.C.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, 593 Eddy Street, Providence, RI 02903; Radiology Human Factors Laboratory, Department of Diagnostic Imaging (M.K.A., G.L.B.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, Providence, Rhode Island.
| | - Grayson L Baird
- Department of Diagnostic Imaging (M.K.A., G.L.B., M.T.S., K.O., J.J.C.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, 593 Eddy Street, Providence, RI 02903; Radiology Human Factors Laboratory, Department of Diagnostic Imaging (M.K.A., G.L.B.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, Providence, Rhode Island
| | - Matthew T Stib
- Department of Diagnostic Imaging (M.K.A., G.L.B., M.T.S., K.O., J.J.C.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, 593 Eddy Street, Providence, RI 02903
| | - Paul George
- Office of Medical Education (P.G.), Warren Alpert School of Medicine of Brown University, Providence, Rhode Island
| | - Karim Oueidat
- Department of Diagnostic Imaging (M.K.A., G.L.B., M.T.S., K.O., J.J.C.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, 593 Eddy Street, Providence, RI 02903
| | - John J Cronan
- Department of Diagnostic Imaging (M.K.A., G.L.B., M.T.S., K.O., J.J.C.), Rhode Island Hospital, Warren Alpert School of Medicine of Brown University, 593 Eddy Street, Providence, RI 02903
| |
Collapse
|
6
|
Oueidat K, Baird GL, Bernstein MH, Kim NJ, Kim D, Dubel GJ, Jay BS, Maxwell AWP. A pilot study of accelerometer-based biometric data collection among patients undergoing locoregional therapies. J Vasc Interv Radiol 2023:S1051-0443(23)00292-0. [PMID: 37100198 DOI: 10.1016/j.jvir.2023.04.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Revised: 03/09/2023] [Accepted: 04/14/2023] [Indexed: 04/28/2023] Open
Abstract
This study evaluated the feasibility of measuring patient recovery following locoregional therapies (LRT) using a wearable activity tracker (WAT). Twenty adult cancer patients were provided with a WAT device to wear for a minimum of seven days prior to their procedure (baseline) and for up to 30 days after their procedure (recovery). Daily step counts were continuously recorded. Patient responses to the SF-36 Health Survey were also collected before and following LRT. Analysis of WAT data demonstrated a mean of 4850 daily steps taken at baseline, which decreased to 2000 immediately following LRT then rapidly increased to approximately 4300 daily steps over an average of 10 days (p<0.001). No significant changes were observed in SF-36 responses between baseline and follow-up assessments (p>0.10). These results suggest that WAT devices capture dynamic peri-procedural data not reflected in survey-based assessments and may be used to monitor patient recovery following interventional oncology procedures.
Collapse
Affiliation(s)
- Karim Oueidat
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903.
| | - Grayson L Baird
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| | - Michael H Bernstein
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| | - Nicole J Kim
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| | - DaeHee Kim
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| | - Gregory J Dubel
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| | - Bryan S Jay
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| | - Aaron W P Maxwell
- The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging, 593 Eddy Street, Providence, RI 02903
| |
Collapse
|
7
|
Bernstein MH, Baird GL, Oueidat K, Agarwal S, Atalay A, Healey S, Healey TT. Heavy Smoking Patients Receiving a Lung Cancer Screen Want to Quit: A Call for Tailored Cessation Interventions. Front Med (Lausanne) 2022; 9:816694. [PMID: 35646966 PMCID: PMC9130603 DOI: 10.3389/fmed.2022.816694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 02/28/2022] [Indexed: 12/03/2022] Open
Abstract
Background Lung cancer screening for current or former heavy smokers is now recommended among all asymptomatic adults 50–80 years old with a 20 pack-year history of smoking. However, little is known about the smoking-related attitudes of this population. Method An assessment was conducted among 1,472 current smokers who presented for an annual lung cancer screen at one of 12 diagnostic imaging sites in Rhode Island between April 2019 and May 2020. Patients were asked about their use of smoking products, interest in quitting, and smoking-related attitudes. Results Patients smoked a median of 16 cigarettes per day; 86.6% were daily cigarette smokers and 30.1% were daily cigar smokers. In total, 91.4% of patients were, to some degree, interested in quitting smoking and 71.4% were seriously thinking about quitting in the next 6 months or sooner. Patients planned on smoking less regardless of whether their lung screen was positive or negative for cancer, though they were more likely to plan on smoking less if negative (on 0–3 pt Likert scale: 0.31, 95% CI [0.27, 0.34] vs. 0.77, 95% CI [0.72, 0.81]). Confidence in quitting and belief in one’s inherent ability to quit smoking varied substantially within the sample. Conclusion Nearly all current smokers receiving a lung cancer screen have some interest in smoking cessation. Due to the heterogeneity in some smoking-related attitudes, tailored interventions for this population should be tested.
Collapse
Affiliation(s)
- Michael H Bernstein
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Providence, RI, United States.,Department of Behavioral and Social Sciences, School of Public Health, Center for Alcohol and Addiction Studies, Brown University, Providence, RI, United States.,Brown Radiology Human Factors Lab, Providence, RI, United States
| | - Grayson L Baird
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Providence, RI, United States.,Brown Radiology Human Factors Lab, Providence, RI, United States.,Lifespan Biostatistics Core, Providence, RI, United States
| | - Karim Oueidat
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Providence, RI, United States
| | - Saurabh Agarwal
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Providence, RI, United States
| | - Alexander Atalay
- Department of Radiology and Medical Imaging, University of Virginia Hospital Medical Center, Charlottesville, VA, United States
| | - Shannon Healey
- Rhode Island Medical Imaging, Providence, RI, United States
| | - Terrance T Healey
- Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Providence, RI, United States
| |
Collapse
|
8
|
Hsieh C, Ward R, Oueidat K, Baird G, Ahn S. Abstract No. 262 Recurrence of breast cancer post-cryoablation in candidates previously excluded from clinical trials. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|